INM
InMed Pharmaceuticals Inc. · Healthcare · Market cap $4.4M
Insiders bought $1.2M net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Jul 17, 2026
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Jul 17, 2026
ADAR1 Capital Management, LLC
InMed Pharmaceuticals Inc. (INM) has 5 SEC Form 4 filings (34 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 17, 2026.
Inside the rolling window, 2 insiders at InMed Pharmaceuticals Inc. reported 17 open-market purchases totaling $1.2M and no open-market sales. The most active filer is 10% Owner Vivo Opportunity, LLC with 15 filings. Insiders have net bought $1.2M over the trailing 6 months. The most recent open-market filing is a purchase of 1,000 shares by 10% Owner ADAR1 Capital Management, LLC, dated Jul 15, 2026, worth $2K.
- Industry:Biotechnology
- CEO:Eric A. Adams Chem.
- Employees:13
- HQ:Vancouver, BC, CA
- IPO:2014-05-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 1,000 | $2K | Jul 17 | -12.5% | SEC ↗ | |
| 10% Owner | Purchase | 5,375 | $8K | Jul 17 | -12.5% | SEC ↗ | |
| 10% Owner | Purchase | 15,150 | $23K | Jul 17 | -12.5% | SEC ↗ | |
| 10% Owner | Purchase | 21 | $33 | Jul 17 | -12.5% | SEC ↗ | |
| 10% Owner | Purchase | 600 | $924 | Jul 2 | -14.7% | SEC ↗ | |
| 10% Owner | Purchase | 4,344 | $7K | Jul 2 | -14.7% | SEC ↗ | |
| 10% Owner | Purchase | 1,607 | $2K | Jul 2 | — | SEC ↗ | |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 56,210 | $88K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 34,000 | $57K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 17,796 | $28K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 16,336 | $25K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 22,848 | $35K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 7,783 | $12K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 6,743 | $11K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 55,011 | $86K | Jun 11 | — | SEC ↗ |
Vivo Opportunity, LLCFirst filing | 10% Owner | Purchase | 32,500 | $49K | Jun 11 | — | SEC ↗ |
| 10% Owner | Purchase | 468,551 | $722K | May 21 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does INM have?
InMed Pharmaceuticals Inc. (INM) has 5 SEC Form 4 filings (34 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jul 17, 2026.
When was the most recent SEC Form 4 filing for INM?
The most recent Form 4 filing for INM on Tracefour is dated Jul 17, 2026.
Who is the most active insider at INM?
The most active SEC Form 4 filer at INM in the rolling window is 10% Owner Vivo Opportunity, LLC, with 15 filings.
What is the net insider flow at INM over the last 6 months?
Over the trailing 180 days, insiders at INM have net bought $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at INM in the current window?
Inside the rolling window, insiders at INM bought $1.2M and sold $0 based on SEC Form 4 filings.
Can I get alerts for INM insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at InMed Pharmaceuticals Inc. (INM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
InMed Pharmaceuticals Inc. is in the Healthcare sector.